OpenVSafe by OpenVAERS
Search V-safe

PU8-23905-72531

2 vaccinations 3 coded responses 6 check-ins 3 free-text entries 3 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
599 / MT
Registered
2021-04-15
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-04
    Dose 1 — Moderna
  2. 2021-04-15
    Registered in v-safe
  3. 2021-04-15
    Dose 2 — Moderna
  4. 2021-04-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-16
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  6. 2021-04-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  7. 2021-04-17
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  8. 2021-04-19
    Survey response — days 1–6 daily, dose 2
    MedDRA: Asthma, Pre-existing disease — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Free text: New significant asthma attack yesterday, unusual.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  10. 2021-04-21
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  11. 2021-05-20
    Survey response — day 35, dose 2
    MedDRA: Cough, Fatigue, Paranasal sinus hypersecretion — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Viral symptoms for the past month (nasal drainage, cough, fatigue.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2022-04-15
    Survey response — 12 months, dose 2
    MedDRA: Breast feeding, Breast pain, Breast tenderness, Fatigue, Upper respiratory tract infection — Feeling: Good
    Free text: Fatigue, recurrent left breast lateral tenderness (side of vaccination x3) with recurrent URIs. Making left side breast feeding more sore (not at the nipple).
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-04Moderna
22021-04-15Moderna

Call center

3 call center cases

3 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-19

Systemic reaction (other): New significant asthma attack yesterday, unusual.

Release 8 — day 35, dose 2

2021-05-20

Symptoms: Viral symptoms for the past month (nasal drainage, cough, fatigue.

Release 11 — 12 months, dose 2

2022-04-15

Symptoms: Fatigue, recurrent left breast lateral tenderness (side of vaccination x3) with recurrent URIs. Making left side breast feeding more sore (not at the nipple).

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBreast feeding · · ✓
SDBreast pain · · ✓
SDBreast tenderness · · ✓
SDCough ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDParanasal sinus hypersecretion ✓ ✓ ✓
SDUpper respiratory tract infection · · ✓
SROAsthma · · ✓
SROPre-existing disease ✓ ✓ ○

✓ active code · ○ coded but marked inactive · blank = not in that release